• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. TRUE DILATATION CATHETER; VALVULOPLASTY BALLOON CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. TRUE DILATATION CATHETER; VALVULOPLASTY BALLOON CATHETER Back to Search Results
Catalog Number 0244512
Medical Device Problem Codes Device Contamination with Chemical or Other Material (2944); Packaging Problem (3007)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/13/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The return of the sample is pending.However, photos were provided for review.The investigation of the reported event is currently underway.H10: d4 (expiry date: 07/2027).H11: section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that prior to valvuloplasty procedure, the device was allegedly damaged.It was further reported that the inner packaging was damaged by water.There was no patient contact.
 
Event or Problem Description
It was reported that prior to valvuloplasty procedure, the device allegedly had water damage.Additional follow-up with the facility found that the secondary packaging (device carton) was unopened, and there were no visible tears, rips, or holes on the devices.The complainant indicated that the damage appeared to be related to shipping, as both the outer shipping carton and secondary packaging showed signs of water damage.The devices were not used on any patients since the damage was identified during inspection at the facility.
 
Additional Manufacturer Narrative
H10: after further review, it was found that the coding in the initial mdr included device contamination ((b)(6)).This was incorrect as the complainant reported water damage.Therefore, the complaint was updated to include only packaging problem ((b)(6) ), which is no longer a reportable event.However, since this event was initially reported, this supplemental report will be submitted to include the findings of the returned device evaluation.One (1) true device secondary packaging carton was received for evaluation from lot gfju0974.When looking at the side of the secondary packaging carton with the product information sticker visible, the top right corner had visible moisture damage.The moisture damage had a slight tan appearance.Moisture damage was noted to the product information label as well.The top right corner of the secondary packaging carton was damaged/deformed.The bottom of the secondary packaging carton from the same perspective was also compressed and had what appeared to be water damage present.When turned over, more water/moisture damage was noted near the top of the secondary packaging carton.The secondary packaging carton was still sealed.The seal was broken during evaluation and the primary tyvek sleeve was removed.The device was still sealed within the primary tyvek sleeve.There was no presence of water or moisture damage to the primary tyvek sleeve or the device.The primary tyvek sleeve seal was still intact and there was no breach of sterile barrier.Additionally, the device history records were reviewed, and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Therefore, the investigation is confirmed for the reported packaging problem as water damage and general damage/compression were seen to the secondary packaging carton and outer shipper box.Based on the provided photos and the review of the manufacturing records, it appears that shipping/transit of the product is the likely source of the water damage to the packaging.H10: g3.H11: b5 (event description), d4 (unique identifier (udi) #), h6 (method, result, conclusion).H11: section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUE DILATATION CATHETER
Common Device Name
VALVULOPLASTY BALLOON CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key20472618
Report Number2020394-2024-01582
Device Sequence Number15354341
Product Code OZT
UDI-Device Identifier00801741091018
UDI-Public(01)00801741091018(11)240819(17)270728(10)GFJU0974
Combination Product (Y/N)N
Initial Reporter StateSD
Initial Reporter CountryUS
PMA/510(K) Number
K150667
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number0244512
Device Lot NumberGFJU0974
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/23/2024
Supplement Date Received by Manufacturer01/09/2025
Initial Report FDA Received Date10/17/2024
Supplement Report FDA Received Date01/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/19/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-